Bentham Science Logo

CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 18, 10 Issues, 2019
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Abstracts Ahead of Print



Gut Microbiome: Lactation, Childbirth, Lung Dysbiosis, Animal Modeling, Stem Cell Treatment, and CNS disorders


Sydney Corey, Lauren Kvederis, Chase Kingsbury, Brooke Bonsack, Paul R. Sanberg, Vanessa Castelli, Jea-Young Lee and Cesar V. Borlongan*


DOI: 10.2174/1871527318666191021145252
View Abstract


Cannabidiol partially blocks the sleepiness in hypocretin-deficient rats. Preliminary data.


Eric Murillo-Rodríguez*, Diana Millán-Aldaco, Marcela Palomero-Rivero, Daniela Morales-Lara, Raphael Mechoulam and René Drucker-Colín


DOI: 10.2174/1871527318666191021143300
View Abstract




Editor-in-Chief

Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA

Biography View Full Editorial Board

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.60

Related Journals

Related eBooks

eBooks Catalog